Advances in Antioxidant Applications for Combating <sup>131</sup>I Side Effects in Thyroid Cancer Treatment

Advances in Antioxidant Applications for Combating <sup>131</sup>I Side Effects in Thyroid Cancer Treatment

Thyroid cancer is the most common endocrine cancer, and its prevalence has been increasing for decades. Approx. 95% of differentiated thyroid carcinomas are treated using <sup>131</sup>iodine (<sup>131</sup>I), a radionuclide with a half-life of 8 days, to achieve optimal thy...

Full description

Bibliographic Details
Main Authors: Li Yang, Jiahui Ma, Pengyu Lei, Jia Yi, Yilei Ma, Zhongke Huang, Tingjue Wang, Haiyan Ping, Danping Ruan, Da Sun, Hongying Pan
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Toxics
Subjects:
thyroid cancer
<sup>131</sup>I
oxidative stress
antioxidant
DNA damage
Online Access:https://www.mdpi.com/2305-6304/11/6/529

Internet

https://www.mdpi.com/2305-6304/11/6/529

Similar Items